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Research
AbstrACt
Objective Fractured neck of femur is a severely painful 
condition with significant mortality and morbidity. We 
investigated whether early and continuous use of femoral 
nerve block can improve pain on movement and mobility 
after surgery in older participants with fragility neck of 
femur fracture.
Design Prospective single-centre, randomised controlled 
pragmatic trial.
setting Secondary care, acute National Health Service 
Trust, UK.
Participants Participants admitted with a history and 
examination suggesting fractured neck of femur.
Intervention Immediate continuous femoral nerve block 
via catheter or standard analgesia.
Outcome measures Primary outcome measures 
were Cumulative Dynamic Pain score and Cumulated 
Ambulation Score from surgery until day 3 postoperatively. 
Secondary outcome measures included pain scores at 
rest, cumulative side effects (nausea and constipation), 
quality of life (measured by EuroQOL 5 D instrument (EQ-
5D) score) at day 3 and day 30, and rehabilitation outcome 
(measured by mobility score).
results 141 participants were recruited, with 23 
excluded. No significant difference was detected between 
Cumulative Dynamic Pain Score (standard care (n=56) 
vs intervention (n=55) 20 (IQR 15–24) vs 20 (15–23), 
p=0.51) or Cumulated Ambulation Score (standard care 
vs intervention 6 (5–9) vs 7 (5–10), p=0.76). There 
were no statistically different differences in secondary 
outcomes except cumulative pain at rest: 5 (0.5–6.5) in 
the standard care group and 2 (0–5) in the intervention 
group (p=0.043).
Conclusions Early application of continuous femoral 
nerve block compared with standard systemic analgesia 
did not result in improved dynamic pain score or superior 
postoperative ambulation. This technique may provide 
superior pain relief at rest. Continuous femoral nerve block 
did not delay initial control of pain or mobilisation after 
surgery.
trial registration number ISRCTN92946117; Pre-results.
IntrODuCtIOn 
There are approximately 75 000 fragility hip 
fractures in the UK each year, with adverse 
effects on life expectancy,1–3 quality of 
life4 5 and significant health and social care 
costs.6 7 In the UK, postoperative mortality 
ranges between 7% and 11% at 1 month, 16% 
and 28% at 6 months and 22% and 37% at 
1 year.1 8 In-hospital postoperative morbidities 
are a more frequent occurrence (17%–50%) 
and often complex. A significant proportion 
of hip fracture survivors has decreased ability 
to perform activities of daily living; 50% do 
not regain their prefracture functional status 
and 10%–20% of those admitted from home 
require long-term institutional care.8 Accu-
rate identification, quantification and care 
of short-term morbidity after hip fracture 
surgery are important since these conditions: 
are strongly associated with mortality and 
length of hospital stay9; impact long-term 
survival10 and resource management.
These fractures result in severe pain and 
optimising pain control is both important and 
problematic in this older group of patients. 
Standard care systemic analgesia paracetamol 
(acetaminophen) is a good first-line treat-
ment11 12 but is insufficient to control severe 
pain. Non-steroidal anti-inflammatory drugs 
are not recommended in this patient popu-
lation.13 Opioids are widely used but may be 
ineffective for pain on movement. Further-
more, their use is associated with poten-
tially serious side effects such as confusion, 
nausea and constipation—all of which may 
strengths and limitations of this study
 ► Study designed to evaluate the role of continuous 
femoral nerve blockade instituted preoperatively 
and maintained up to 48 hours postoperatively to im-
prove pain on movement and mobility after surgery.
 ► Relatively lower infusion rate may not have provided 
sufficient spread of local anaesthetic, and a different 
dose regimen may have given a different result.
 ► We did not include patients with cognitive impair-
ment who may have more to benefit from regional 
anaesthetic techniques.
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significantly impact on rehabilitation following fractured 
neck of femur.14 15
Regional anaesthetic techniques have the theoretical 
advantage of avoiding the systemic effects of opioid anal-
gesia, while providing analgesia that targets pain both 
at rest (static) and on movement (dynamic).12 Various 
peripheral nerve blocks have been described for use in 
hip fracture and are increasingly being used in the UK.4 16 
Of these, femoral and fascia iliaca compartment blocks 
are the most commonly performed. However, many of 
these studies have generally focused on short-term anal-
gesic effects of single-shot nerve blocks. Pain on move-
ment following hip fracture lasts for at least the first 
few days, before and after surgery, therefore single-shot 
nerve blocks may have limited patient benefit. While pain 
relief per se is clearly of value, the additional beneficial 
effects of pain relief both directly and indirectly through 
avoidance of opioids have not been well investigated. No 
study has examined the effects of continuous femoral 
nerve blockade instituted preoperatively compared with 
traditional (standard care) medication on pain, rehabil-
itation and adverse events. We, therefore, undertook a 
randomised, controlled trial comparing early (preopera-
tively) continuous use of femoral nerve block to standard 
oral analgesic therapy on pain and mobility after surgery 
in older participants with fragility neck of femur fracture.
MethODs
This was a pragmatic, two-arm randomised controlled trial 
in a single centre. The study was registered with EudraCt 
(ref: 2010-023871-25 (17/02/2011)) and ISRCTN: 
ISRCTN92946117. There was a delay in trial registration 
due to administration oversight, but no changes in the 
protocol were made between first patient recruitment 
and trial registration.
Participants
We recruited participants aged 70 years and over 
admitted directly to the Emergency Department (ED) of 
Queen’s Medical Centre, Nottingham University Hospi-
tals NHS Trust, UK (Monday–Friday, 08:00–18:00), with 
a suspected fractured neck of femur. Patients had to be 
without significant cognitive impairment (Abbreviated 
Mental score of ≥7 out of 10)17 and therefore able to 
provide informed consent, resident in their own home 
or warden aided flat, with a New Mobility Score of 3 or 
more prior to presentation to ED (indicating indepen-
dent indoor ambulation).18
Exclusion criteria included prefracture hospitalisa-
tion, contraindications to femoral nerve block analgesia, 
regular prefracture opioid or glucocorticoid therapy, 
alcohol or substance abuse, documented serious adverse 
reaction to morphine, restrictions to their postoperative 
mobilisation or already participating in another clinical 
trial and participants, who in the opinion of the investi-
gator, had any condition which would adversely affect the 
study.
Consent was undertaken as a two-stage process. Initial 
witnessed verbal consent was obtained by investigators in 
the ED. This was to allow rapid consent and application 
of an initial block before participants were transferred for 
X-ray. Formal written consent was then obtained 24 hours 
later. In participants who developed confusion and were 
therefore deemed not to have capacity to consent at 
24 hours, assent was sought from the next of kin or first 
nominated point of contact. If capacity was regained, 
formal written consent was obtained from the participant 
at this time.
Intervention
Participants were randomised to intervention (active) 
or standard care. The intervention was a femoral nerve 
block using 0.5 mL/kg of 0.25% levobupivacaine (Chiro-
caine, Abbott Pharmaceuticals, Maidenhead, UK) up to 
a maximum of 30 mL. This was provided immediately 
after verbal consent and was performed under ultra-
sound guidance by an anaesthetic research fellow in ED. 
A 50 mm linear high-frequency ultrasound transducer 
(S-Nerve or Micromaxx, FUJIFILM Sonosite, London, 
UK) was placed in the groin crease and the femoral nerve 
identified lateral to the femoral artery and just deep 
to fascia iliaca. A 50 or 100 mm short-bevelled regional 
block needle (Stimuplex A, B.Braun, Melsungen, Hessen, 
Germany) was inserted under the transducer ‘in-plane’ 
with the ultrasound beam in a lateral to medial direc-
tion and local anaesthetic injected around the nerve as 
described above. Following confirmation of fracture of 
the femoral neck, participants had a femoral nerve cath-
eter sited using the same ultrasound-guided approach 
described above, under aseptic conditions in a ‘block 
room’ during transfer of the participant from ED to the 
orthopaedic ward. The perineural catheter (Contiplex 
Tuohy, B.Braun) was positioned under direct vision and 
the position deep to the nerve confirmed by injection of 
a small bolus of normal saline. The catheters were then 
tunnelled subcutaneously towards the anterior superior 
iliac spine, away from the expected operative site and 
fixed to the skin using glue (Histoacryl, B-Braun Medical, 
Sheffield, UK) and a transparent dressing (Tegaderm 3M 
Healthcare, Bracknell, UK). The nerve block was then 
maintained with an infusion of 0.2% ropivacaine at 5 mL/
hour (Naropin, AstraZeneca, Luton, UK) by means of an 
elastomeric pump (Surefuser+ 250, Nipro Europe, Breda, 
The Netherlands) for 48 hours after surgery. The blocks 
were all performed by consultant-level and senior train-
ee-level research fellows, all with over 5 years of regional 
anaesthesia experience.
Participants in the standard care group received titrated 
intravenous morphine to a pain score of 5 or less at rest 
(verbal rating 10-point scale) before transfer to X-ray. All 
other care protocols were identical between the standard 
care and intervention group. Standard care was in accor-
dance with national guidelines.13 19 20 All participants were 
prescribed regular paracetamol (1 g in every 6 hours) and 
tramadol (50–100 mg in every 6 hours). Breakthrough 
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analgesia was oral morphine liquid (10–20 mg up to 
4 hourly) and was available for both groups as required.
Surgical fixation was determined by the operative 
orthopaedic surgeon following multidisciplinary review, 
in line with national recommendations.13 20 The anaes-
thetic technique was left to the discretion of the operating 
anaesthetist. Standard care participants were permitted to 
have a single-shot femoral nerve block, also at the discre-
tion of the operating anaesthetist as it was felt unethical 
to deprive participants of this commonly used technique.4 
Intervention group participants were permitted a cath-
eter bolus of local anaesthetic. The choice of spinal or 
general anaesthesia was at the discretion of the attending 
anaesthetist.
Primary outcome measures
Our primary outcome measures were the Cumulated 
Ambulation Score (CAS) and Cumulative Dynamic Pain 
Score and from day 1 to day 3 postoperatively. Baseline 
was defined as the first set of study-recorded data after 
participant consent.
The CAS is a validated mobility scoring system 
consisting of three functional domains scored 0–2 for a 
maximum score of 6. The domains are: getting in and 
out of bed; sitting to standing and walking. Each domain 
is scored: 0=unable to perform task, 1=can perform with 
assistance, 2=can perform independently.18 21 Participants 
were assessed daily, unblinded by the ward physiothera-
pist. The score was calculated daily for three postopera-
tive days, giving a maximum possible score of 18.
Cumulative Dynamic Pain Score was assessed unblinded 
by the research team using a 10-point verbal rating scale 
(0=no pain, 10=worst pain experienced). Once on each of 
the 3 days, the affected limb was elevated by 15° and pain 
assessed. If attempted elevation of the leg was intolerable 
then it was abandoned and a score of 10 allocated. This 
gave a maximum score of 30 over the 3 days. The pain 
score at rest was assessed immediately before the dynamic 
pain score. Baseline pain scores were obtained immedi-
ately before randomisation.
secondary outcome measures
Secondary outcome measures were: pain scores in the 
first 180 min following randomisation; pain scores at 
rest; presence of side effects (nausea and constipation); 
calorific and protein intake; quality of life (measured by 
EuroQOL 5D score (EQ-5D) (https:// euroqol. org/)) at 
day 3 and day 30; length of acute hospital stay and reha-
bilitation outcome (measured by mobility score, at the 
time of discharge).18
For constipation, Bristol stool charts were kept for 
three postoperative days. Constipation was deemed to 
have occurred if participants had no bowel movements 
on any of the 3 days.
Nausea and vomiting were scored on a 5-point scale: 
0=no nausea/vomiting; 1=mild nausea only—no treat-
ment required; 2=nausea only, antiemetics given; 
3=vomiting, antiemetics given and 4=nausea/vomiting 
unresponsive to administered antiemetics. Participants 
who required treatment for nausea or vomiting (score 
of 2 or greater) were deemed to have had an episode 
of nausea or vomiting. Participants were considered 
to have experienced nausea/vomiting if they had any 
episodes of nausea/vomiting across any of the 3-day 
study period.
effectiveness of the blocks
Effectiveness of the block was checked by assessing loss 
of cold sensation to ethyl chloride spray over the patella. 
Blocks were considered effective if cold sensation was 
altered or lost. Participants in the intervention group who 
had a catheter failure or dislodgement within the first 
24 hours had their catheters resited. Dislodgements after 
24 hours were switched to oral analgesia but remained in 
the intervention group for analysis on an intention-to-
treat basis.
statistical methods
Sample size was estimated from previously published data 
for the mean dynamic pain scores22 and mean CAS.23 For 
the Cumulated Dynamic Pain Score, a sample size of 67 
participants per group was estimated to detect a clinically 
relevant 2.5-point difference in mean scores between the 
two groups on a 10-point pain scale. For the CAS, sample 
size of 37 participants per group was estimated to be 
required to detect a clinically relevant 2-point difference 
in the mean CAS. Therefore, a total sample size of 150 
(75 per arm) was estimated to allow a 2.5 difference in 
pain score and 1.5 difference in CAS, allowing for 10% 
attrition rate and assuming a two-sided significance level 
of 0.05% and 80% power.
Participants were randomised to intervention (active) 
or standard care group using a web-based randomisation 
service provided by the Nottingham Clinical Trials Unit. 
The randomisation sequence was generated using the 
ralloc module in Stata V.10.0 (StataCorp) statistical soft-
ware; study participants were the unit of randomisation 
and were randomised with a 1:1 allocation using random 
block sizes of 2, 4 and 6 since placebo ‘block catheters’ 
were considered unethical, participants, staff and asses-
sors were not blinded to group allocation.
Statistical analysis was undertaken on an intention-
to-treat basis and conformed to a prespecified statis-
tical analysis plan. Group allocation was blinded to the 
statistical team until analysis was complete. Compar-
ison of CAS and cumulative pain scores was performed 
using Mann-Whitney U test. Secondary outcome vari-
ables were compared using the independent samples 
t-test for continuous outcomes or the Mann-Whitney 
U test if assumptions for using the t-test were not satis-
fied after appropriate transformations of the data had 
been applied. Binary and categorical data were analysed 
using the χ2 test. Data on pain on movement at 30, 60 
and 180 min, and similarly pain at rest were recorded for 
descriptive purposes and formal statistical comparisons 
between groups were not performed. A significance level 
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of 0.05 was used for all analyses. Fuller details of the trial 
protocol have been published previously.24
results
The first participant was randomised on 6 January 2012 
and the final participant on 1 December 2014. Recruit-
ment to the study was slower than anticipated for several 
reasons: lack of out-of-hours and weekend cover; the inclu-
sion requirement for both mental capacity and mobility 
(approximately one in three patients lacked capacity on 
initial assessment) and the requirement for a high degree 
of clinical certainty of fracture. A total of 1224 patients 
presenting to the ED with hip pain were assessed for eligi-
bility, of whom 1081 were excluded (225 did not fit inclu-
sion criteria; 16 declined to participate; 842 were deemed 
not to have a fracture clinically). Of the remaining, 141 
participants were randomised into the study. Seventy-one 
patients were allocated to the intervention, 12 further 
excluded because no hip fracture was shown on X-ray 
and 59 continued to the intervention. Fifty-five of these 
were included in the final analysis (four excluded: one 
death and three discontinued the intervention-1 exclu-
sion criteria discovered at day 1, one protocol violation, 
one randomised but no anaesthetic cover for block). 
Seventy patients were allocated to standard care, of which 
11 were further excluded because no hip fracture seen on 
the X-ray and 59 continued within the study. Of these, 56 
were included in the final analysis (three excluded due to 
one exclusion criteria discovered at day 1, one protocol 
violation and one withdrew consent; figure 1).
The groups were well balanced at baseline (table 1). 
One hundred and eleven participants completed the 
full follow-up and were included in the primary analysis 
(table 2). The median Cumulative Dynamic Pain Scores 
Figure 1 Consolidated Standards of Reporting Trials flow diagram.
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were 20 (15–24) in the standard care group and 19.5 
(15–3) in the intervention group (p=0.51). The median 
CAS was 6 (5–9) in the standard care group and 7 (5–10) 
in the intervention group (p=0.76). Cumulative pain 
scores at rest were statistically different: 5 (0.5–6.5) in 
the standard care group and 2 (0–5) in the intervention 
group (p=0.043).
There were more spinal anaesthetics in the inter-
vention group than the standard care group and this 
difference achieved statistical significance (general 
anaesthesia 29/56 in the standard care group vs 39/55 
in the intervention group, p=0.039). There were no 
significant differences in the remaining secondary 
outcomes (table 3). Despite the efforts of the research 
team, routine protein calorific intake was recorded in less 
than 10% of participants and therefore not reliable.
Time from randomisation to theatre was not statisti-
cally different between the two groups: standard care 22.5 
Table 1 Summary of patient characteristics
Intervention
Standard 
care (n=59)
Intervention 
(n=59)
Age at inclusion 83.9 (6.24) 83.0 (5.81)
84 (79–90) 83 (79–88)
Gender Female 48 (76%) 54 (81%)
Male 15 (24%) 13 (19%)
Body mass index (kg) 23.9 (3.98)
24 (22–26)
23.6 (4.94)
24 (20–27)
Residential 
status
Lives alone 32 (52.5%) 39 (58%)
Lives with 
others
29 (47.5%) 28 (42%)
ASA grade I 3 (6%) 2 (4%)
II 45 (83%) 40 (71%)
III 6 (11%) 12 (21%)
IV 0 2 (4%)
V 0 0
Pain at rest 4.92 (3.18) 4.28 (3.14)
5 (2–7) 5 (1–7)
Pain on movement 9.59 (0.99) 9.65 (1.14)
10 (10–10) 10 (10–10)
New Mobility Score on 
admission (CAS)
7.26 (1.56) 7.14 (1.52)
7 (6–9) 7 (6–9)
EuroQol EQ-5D 6.52 (1.53) 6.57 (1.79)
6 (5–8) 6 (5–7)
Values are mean (SD), median (IQR or proportion).
ASA, American Society of Anaesthesiologists; CAS, Cumulated 
Ambulation Score. 
Table 2 Primary outcome measures
Variable
Standard care 
(n=56)
Intervention 
(n=55)
P 
values
Cumulated 
Ambulation Score
7.41 (3.70)
6 (5–9)
7.51 (3.25)
7 (5–10)
0.76
Cumulative 
Dynamic Pain 
Score
19.4 (6.29)
20 (15–23.8)
18.67 (5.97)
19.5 (14.5–23)
0.51
Values are mean (SD), median (IQR or proportion). Outcomes were 
compared using Mann-Whitney U test. 
Table 3 Secondary outcome measures
Secondary 
outcomes
Standard care 
(n=56)
Intervention 
(n=55)
P 
values
Length of stay 15.9 (10.67) 16.2 (9.56)
14 (9.25–19.5) 13 (10–18) 0.89
Pain on movement 
at 30 min
9.62 (1.29) 9.11 (1.45)
10 (10–10) 10 (8–10)
Pain on movement 
at 60 min
9.4 (1.59) 8.84 (1.99)
10 (10–10) 10 (8.25–10)
Pain on movement 
at 180 min
9.35 (1.17) 8.68 (1.91)
10 (9–10) 9 (8–10)
Pain on rest at 
30 min
3.64 (2.73) 2.92 (2.77)
3 (1–5) 2 (0–4.5)
Pain on rest at 
60 min
3.28 (2.69) 2.27 (2.46)
3 (1–5) 2 (0–4)
Pain on rest at 
180 min
2.76 (2.61) 2.16 (2.35)
2 (1–4) 1 (0–3.25)
Cumulative pain 
score at rest
4.92 (4.75) 3.16 (3.54)
5 (0.5–6.5) 2 (0–5) 0.043
Presence of 
delirium
4/54 (7.4%) 0/54 (0%) 0.118*
Presence of 
constipation
30/54 (56%) 25/50 (50%) 0.57*
Presence of 
nausea/vomiting
6/56 (10.7%) 5/51 (9.8%) 0.877*
New mobility 
score at 30 days
2.5 (2.08) 2.34 (2.39)
2 (0–4) 2 (0–3) 0.49
EuroQol EQ-5D at 
30 days
8.79 (2.20) 8.67 (2.10) 0.78†
9 (7–10) 8 (7–10)
EuroQol EQ-5D at 
3 days
9.92 (1.52) 9.65 (1.42) 0.37
10 (9–11) 10 (9–10)
Values are mean (SD), median (IQR or proportion). The p values 
reported were obtained from the Mann-Whitney U test unless 
otherwise stated. Binary and categorical data were analysed using 
the χ2 test. 
*P values obtained from the χ2 test.
†P values obtained from the two-sample t-test.
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(19.6–25.2) hours, intervention 23.6 (20.1–25.6) hours, 
(p=0.412). Two participants required catheter resites 
and four catheters were withdrawn early due to dislodge-
ment (after 24 hours but before 48 hours). Unfortunately, 
block assessment was incorrectly coded by a member of 
the research team for an unknown number of partici-
pants (absence of sensation was recorded as an absence of 
block and vice versa). Daily surveillance for block-related 
complications did not result in any cases of suspected 
nerve damage, haematoma or infection. There were no 
falls in the block group during the study period. One 
patient fell in the standard care group.
DIsCussIOn
Early (preoperatively) and continuous (up to 48 hours 
postoperatively) femoral nerve block was not associated 
with improvements in Cumulative Dynamic Pain Scores 
or mobility from surgery to 3 days postoperatively. There 
was a significant difference in pain scores at rest but no 
observed benefit on opioid-related side effects (nausea, 
constipation) nor a range of surrogate markers of 
recovery. We have demonstrated that pain on movement 
is severe both before and after surgery and in the early 
postoperative period.
Our results seemingly run counter to current recom-
mendations and to an extent clinical practice. It is,  there-
fore, appropriate to critique both the intervention and 
the outcome measures used in the study.
Pain mechanism
Pain following fractured neck of femur is usually severe 
and while early assessment and treatment of pain is 
recommended,13 National Institute for Health and Care 
Excellence (NICE) guidelines only recommend nerve 
blocks when regular oral analgesics (paracetamol and 
opioids) are failing to control pain. It is also recognised 
by NICE that use of nerve blocks should not prevent early 
surgical fixation.
Pain from fractured neck of femur is complex and 
multifactorial involving muscle spasm, fracture move-
ment, surgical wounds and psychosocial factors. Femoral 
nerve block will only impact on part of this process. The 
hip joint itself receives innervation from several nerves.25 
A common comment from participants in the interven-
tion arm was that pain seemed to migrate from the front 
of the hip to the back. This is consistent with the sensory 
block expected from femoral nerve block and the lack 
of blockade of the sciatic and probably obturator nerves. 
Techniques which target more of the nerves supplying 
the hip have shown improvements in pain,15 16 23 26 but 
not necessarily other endpoints.
Optimal regional anaesthesia
Precise placement of nerve sheath catheters with ultra-
sound guidance can provide a more effective block of the 
lumbar plexus than those guided by nerve stimulator. Use 
of the ultrasound has been shown to be more effective than 
increasing the volume of local anaesthetic for single-shot 
blocks. It was anticipated that the 5 m/hour infusion rate 
would provide effective analgesia without compromising 
motor function and mobility. On reflection, we accept that 
this lower infusion rate may not have provided sufficient 
spread of local anaesthetic. In addition, at the outset of 
study design we carefully considered the balance between 
analgesia and motor blockade. A different dose regimen 
may have given a different result; intermittent bolusing 
rather than continuous infusion is another possibility. 
Other studies of femoral nerve catheter local anaesthetic 
infusions have shown mixed results. Szucs et al used an 
infusion of 0.25% bupivacaine at 4 mL/hour and demon-
strated reduced pain scores on passive movement at all 
time points up to 72 hours.27 Chaudet et al28 used ropiva-
caine 2 mg/mL (the same as this study) but at 8 mL/hour 
(compared with 5 mL/hour in this study). They found no 
difference in pain scores between local anaesthetic and 
placebo infusion groups. A reduction in morphine-associ-
ated side effects (predominantly nausea) was seen despite 
no difference in total morphine consumption. Gille et al29 
used the same infusion regimen as this study and found 
no difference in pain relief between the catheter group 
and a systemic analgesia group over 3 days. A retrospec-
tive database study from Helsø et al30 found no differ-
ence in morphine consumption during the first 5 days of 
admission between those given continuous femoral nerve 
blockade and those without.
Although it is possible that the greater proportion of 
spinal anaesthetics in the block group may have affected 
analgesia in the very early postoperative period, we do not 
think that an effect would have been observed over the 
three postoperative days.
More complete coverage of the hip joint would be 
expected from epidural analgesia. Foss et al31 demon-
strated a significant reduction in a 5-point pain scale with 
such an approach, though without an overall benefit in 
terms of early mobilisation or hospital discharge and with 
an increase in nausea. In a study comparing continuous 
femoral nerve blockade with participant controlled intra-
venous morphine and continuous epidural analgesia in 
elective hip surgery, no differences were found in quality 
of analgesia although the femoral nerve block was asso-
ciated with fewer side effects.28 Other studies of similar 
design have not reported differences in pain scores.26 
Epidural analgesia is uncommon in UK practice in this 
group of patients, with concerns about nursing time, 
catheter fall out and falls secondary to bilateral motor 
and proprioceptive block.
The use of a relatively high dose of tramadol might 
have reduced any difference seen between the groups. 
However, at the time of study design this was considered 
to be a reasonable standard of analgesia and we felt it 
would have been unethical to deny this to participants. 
We acknowledge that clinical practice has changed in the 
intervening period and oral morphine or oxycodone is 
more commonly used now. Furthermore, the reported 
dynamic pain scores in both groups were high. Tramadol 
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does not appear to be effective for preventing severe 
dynamic pain.
limitations of the study
The incorrect coding of block assessment was a result of 
(unnoticed) confusion between absence of sensation and 
presence of a block. However, even had these been coded 
correctly, the study was intended as a pragmatic study 
with all blocks and catheters placed by experienced clini-
cians. Dynamic pain may be a better endpoint than static 
pain. In common with other studies,27 our results showed 
that static pain is relatively well controlled following hip 
fracture. But, it is dynamic pain that is felt to impact on 
rehabilitation. Analgesia sufficient to allow movement 
necessary for investigations is also a NICE recommenda-
tion.13 The pain scores reported by participants in this 
study were considerably higher than those reported by 
Foss et al, both in the intervention and control groups. 
Given that the pathology of hip fracture is the same, we 
can only surmise that the interpretation of a pain score is 
different between older people in England and Denmark. 
There is reasonable evidence for the use of pain scales 
in older people and many similar studies have used the 
verbal rating scale in similar populations.12 31–33
We did not collect data on morphine consumption as 
morphine consumption is of little direct relevance: partic-
ipants are concerned with quality of analgesia and adverse 
effects. One of the perceived benefits to the use of nerve 
block techniques is the opioid-sparing effect that they 
provide. Unlike Chaudet et al,28 we found no difference in 
common opioid-related side effects (nausea and consti-
pation); Helsø et al30 found no morphine-sparing effect. 
The relatively low nausea rates in this study compared 
with others may explain some of this difference. The rates 
of delirium recorded during the study were low, with no 
significant difference between the groups. This may, in 
part be due to the exclusion of patients with dementia—a 
strong risk factor for delirium, and those with impaired 
cognitive function on admission. Our participants would 
therefore represent a lower risk group for delirium. We 
acknowledge that analgesia is not the only factor that 
influences postoperative mobility, and other medical 
conditions will have an impact. The fact that there were 
more spinal anaesthetics than general anaesthetics may 
represent a soft marker of efficacy. Standard practice in 
our institution is to place a femoral nerve block and then 
sit participants forward to place a subarachnoid block for 
surgical anaesthesia. Participants who are obviously in too 
much discomfort to sit forward are often given a general 
anaesthetic. The proportion of spinal anaesthetics given 
in the intervention group may represent participants 
generally being more comfortable being sat forward, but 
there may be other reasons.
Due to the design of the study only including patients 
with mental capacity and good mobility, the participants 
were generally somewhat fitter than the overall hip frac-
ture population.34 The frailer population may have more 
to gain from better analgesia in terms of enhancing 
mobility and avoidance of delirium; this study was not 
designed to assess this. However, we failed to demonstrate 
an analgesic benefit and there is no plausible explanation 
for why femoral nerve blocks would be more effective in 
frailer older people.
Finally, pain from hip fracture starts at the time of injury 
and it may be that earlier intervention is appropriate. 
The time from injury to assessment in ED (and therefore 
trial recruitment) can be prolonged and vary consider-
ably between individuals. Although this is a potential 
unmeasured confounder, we believe that randomisation 
is likely to have balanced the groups. Trials of fascia iliaca 
compartment block delivered by paramedics35 are taking 
place, and we await the results with interest. Although the 
exclusion of participants who were found not to have a 
fractured neck of femur meant that we did not reach our 
recruitment target, we do not believe further recruitment 
would have altered our results in a meaningful way. The 
lack of difference between the two groups was such that a 
statistically significant difference would be almost impos-
sible to achieve.
COnClusIOn
In summary, we do not believe that the widespread use 
of femoral nerve blocks should be abandoned on the 
basis of one negative study. However, previous studies 
looking at pain in fractured neck of femur participants 
receiving femoral nerve catheters perioperatively report 
mixed results.9 24–27 Our study does not provide evidence 
to support the widespread introduction of femoral nerve 
catheters for prolonged infusion. Pain following frac-
tured neck of femur and surgery remains an unresolved 
problem, with a lack of good evidence to support any 
single technique.
Future studies need to look at the effects of extended 
block of the hip in terms of rehabilitation and analgesic 
side effects. There may be benefit in investigating higher 
dose or intermittent bolus regimens. Blockade of more of 
the nerves supplying the hip may be able to demonstrate 
benefit in cumulative outcomes rather than acute anal-
gesic effects. Early and continuous femoral nerve block is 
not superior to standard analgesia in terms of its effect on 
dynamic pain relief or cumulated postoperative ambula-
tion. Femoral nerve block does not delay initial control of 
pain or mobilisation after surgery.
Acknowledgements The study team would like to acknowledge and express 
thanks for the support and participation of the Nottingham University Hospitals NHS 
Trust as well as all individuals and groups who agreed to take part. In addition, 
further acknowledgement is needed for the participants and families who shared 
with the study team their personal and often protracted experiences of hospital care 
and community follow-up. The study team would also like to express thanks for 
the support and guidance of the Trial Steering Committee (TSC): Dr Nicola Morgan 
and Dr Pascal Brodie. Many thanks to the research team nurses Tsvetely Angelova, 
Alison Watson, Anna Gibbs, Lani Patterson, Sally Lee, Leigh DeVivo without 
whom the study could not have been completed, and Dr Mohammed Rafi and Dr 
Lakshmipathy Purushuthaman who also contributed.
Contributors OS, IKM, NB and SA were involved in the design, conduct, analysis 
and writing of the study. MR, GvdW, JB and AM were involved in the conduct, 
analysis and writing of the study.
group.bmj.com on April 11, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
8 Rowlands M, et al. BMJ Open 2018;8:e019650. doi:10.1136/bmjopen-2017-019650
Open Access 
Funding This work was supported by a grant from the National Institute of Health 
Research, UK. (NIHR Project Number: PB-PG-0909-19119).
Competing interests None declared.
Patient consent Obtained.
ethics approval The study was approved by Nottingham Research Ethics 
Committee, Reference 10/H0408/113 (28/1/2011).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No further unpublished data are available.
Open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
reFerenCes
 1. NHFD. Annual report. 2017 http://www. nhfd. co. uk/ 20/ hipfractureR. 
nsf/ docs/ 2017Report (accessed on 30 Oct 2017).
 2. Haentjens P, Magaziner J, Colón-Emeric CS, et al. Meta-analysis: 
excess mortality after hip fracture among older women and men. Ann 
Intern Med 2010;152:380–90.
 3. Marufu TC, White SM, Griffiths R, et al. Prediction of 30-day mortality 
after hip fracture surgery by the Nottingham Hip Fracture Score and 
the Surgical Outcome Risk Tool. Anaesthesia 2016;71:515–21.
 4. White SM, Moppett IK, Griffiths R, et al. Secondary analysis of 
outcomes after 11,085 hip fracture operations from the prospective 
UK Anaesthesia Sprint Audit of Practice (ASAP-2). Anaesthesia 
2016;71:506–14.
 5. Parsons N, Griffin XL, Achten J, et al. Outcome assessment after hip 
fracture: is EQ-5D the answer? Bone Joint Res 2014;3:69–75.
 6. Peeters CM, Visser E, Van de Ree CL, et al. Quality of life after 
hip fracture in the elderly: a systematic literature review. Injury 
2016;47:1369–82.
 7. Lawrence TM, White CT, Wenn R, et al. The current hospital costs of 
treating hip fractures. Injury 2005;36:88–91.
 8. Smith PAC, Bardsley M. Focus on hip fracture: trends in emergency 
admissions for fractured neck of femur, 2001 to 2011. The Health 
Foundation and the Nuffield Trust, 2013. http://www. nuffieldtrust. org. 
uk/ sites/ files/ nuffield/ publication/ 131010_ focus- on- hip- fracture. pdf 
(accessed 20 Dec 2016).
 9. Howes TE, Cook TM, Corrigan LJ, et al. Postoperative morbidity 
survey, mortality and length of stay following emergency laparotomy. 
Anaesthesia 2015;70:1020–7.
 10. Moonesinghe SR, Harris S, Mythen MG, et al. Survival after 
postoperative morbidity: a longitudinal observational cohort study. Br 
J Anaesth 2014;113:977–84.
 11. Foss NB, Kristensen MT, Palm H, et al. Postoperative pain after hip 
fracture is procedure specific. Br J Anaesth 2009;102:111–6.
 12. Cuvillon P, Ripart J, Debureaux S, et al. Analgesia after hip fracture 
repair in elderly patients: the effect of a continuous femoral nerve 
block: a prospective and randomised study. Annales Françaises 
d'Anesthésie et de Réanimation 2007;26:2–9.
 13. National Institute for Health and Care Excellence. The management 
of hip fracture in adults. National Clinical Guideline Centre. 2011 
https://www. nice. org. uk/ guidance/ cg124 (accessed 27 Jun 2017).
 14. Trads M, Pedersen PU. Constipation and defecation pattern the first 
30 days after hip fracture. Int J Nurs Pract 2015;21:598–604.
 15. Carpintero P, Caeiro JR, Carpintero R, et al. Complications of hip 
fractures: A review. World J Orthop 2014;5:402–11.
 16. Guay J, Parker MJ, Griffiths R, et al. Peripheral nerve blocks for hip 
fractures. Cochrane Database Syst Rev 2017;5:CD001159.
 17. Hodkinson HM. Evaluation of a mental test score for assessment of 
mental impairment in the elderly. Age Ageing 1972;1:233–8.
 18. Parker MJ, Palmer CR. A new mobility score for predicting mortality 
after hip fracture. J Bone Joint Surg Br 1993;75:797–8.
 19. Department of Health Payment by Results Team. Payment by results 
guidance for 2013-14. London: Department of Health, 2013. https://
www. gov. uk/ government/ publications/ payment- by- results- pbr- 
operational- guidance- and- tariffs. (accessed 27 Jun 2017).
 20. The care of patients with fragility fracture (The blue book). London: 
British Orthopaedic Association, 2012. https://www. boa. ac. uk/ wp- 
content/ uploads/ 2014/ 12/ BOAST- 1. pdf. (accessed 16 Oct 2017).
 21. Kristensen MT, Jakobsen TL, Nielsen JW, et al. Cumulated 
Ambulation Score to evaluate mobility is feasible in geriatric 
patients and in patients with hip fracture. Dan Med J 
2012;59:A4464.
 22. Olsen MF, Bjerre E, Hansen MD, et al. Pain relief that matters to 
patients: systematic review of empirical studies assessing the 
minimum clinically important difference in acute pain. BMC Med 
2017;15:35.
 23. Foss NB, Kristensen BB, Bundgaard M, et al. Fascia iliaca 
compartment blockade for acute pain control in hip fracture 
patients: a randomized, placebo-controlled trial. Anesthesiology 
2007;106:773–8.
 24. Sahota O, Rowlands M, Bradley J, et al. Femoral nerve block 
Intervention in Neck of Femur fracture (FINOF): study protocol for a 
randomized controlled trial. Trials 2014;15:189.
 25. Birnbaum K, Prescher A, Hessler S, et al. The sensory innervation of 
the hip joint--an anatomical study. Surg Radiol Anat 1997;19:371–5.
 26. Beaudoin FL, Nagdev A, Merchant RC, et al. Ultrasound-guided 
femoral nerve blocks in elderly patients with hip fractures. Am J 
Emerg Med 2010;28:76–81.
 27. Szucs S, Iohom G, O'Donnell B, et al. Analgesic efficacy of 
continuous femoral nerve block commenced prior to operative 
fixation of fractured neck of femur. Perioper Med 2012;1:4–8.
 28. Chaudet A, Bouhours G, Rineau E, et al. Impact of preoperative 
continuous femoral blockades on morphine consumption and 
morphine side effects in hip-fracture patients: A randomized, 
placebo-controlled study. Anaesth Crit Care Pain Med 
2016;35:37–43.
 29. Gille J, Gille M, Gahr R, et al. [Acute pain management in proximal 
femoral fractures: femoral nerve block (catheter technique) vs. 
systemic pain therapy using a clinic internal organisation model]. 
Anaesthesist 2006;55:414–22.
 30. Helsø I, Jantzen C, Lauritzen JB, et al. Opioid Usage During 
Admission in Hip Fracture Patients-The Effect of the Continuous 
Femoral Nerve Block. Geriatr Orthop Surg Rehabil 2016;7:197–201.
 31. Foss NB, Kristensen MT, Kristensen BB, et al. Effect of postoperative 
epidural analgesia on rehabilitation and pain after hip fracture 
surgery: a randomized, double-blind, placebo-controlled trial. 
Anesthesiology 2005;102:1197–204.
 32. Singelyn FJ, Ferrant T, Malisse MF, et al. Effects of intravenous 
patient-controlled analgesia with morphine, continuous epidural 
analgesia, and continuous femoral nerve sheath block on 
rehabilitation after unilateral total-hip arthroplasty. Reg Anesth Pain 
Med 2005;30:452–7.
 33. Herr KA, Garand L. Assessment and measurement of pain in older 
adults. Clin Geriatr Med 2001;17:457–78.
 34. Johansen A, Tsang C, Boulton C, et al. Understanding mortality rates 
after hip fracture repair using ASA physical status in the National Hip 
Fracture Database. Anaesthesia 2017;72:961–6.
 35. Bulger JK, Brown A, Evans BA, et al. Rapid analgesia for prehospital 
hip disruption (RAPID): protocol for feasibility study of randomised 
controlled trial. Pilot Feasibility Stud 2017;3:8.
group.bmj.com on April 11, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
controlled trial
Femur Fracture (FINOF): a randomised 
Femoral Nerve Block Intervention in Neck of
Sarah Armstrong, Nigel Bedforth, Iain K Moppett and Opinder Sahota
Martin Rowlands, Gerrie van de Walt, Jim Bradley, Alexa Mannings,
doi: 10.1136/bmjopen-2017-019650
2018 8: BMJ Open
 http://bmjopen.bmj.com/content/8/4/e019650
Updated information and services can be found at: 
These include:
References
 http://bmjopen.bmj.com/content/8/4/e019650#ref-list-1
This article cites 30 articles, 1 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (120)Anaesthesia
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on April 11, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
